Anti-Invasive and Anti-Metastasis Strategies: New Roads, New Tools and New Hopes
Journal:
Current Cancer Drug Targets
Volume:
6
Page:
729-751
Author(s):
Laurent Dolle, Herman T. Depypere and Marc E. Bracke
ERRATUM
Journal:
Current Cancer Drug Targets
Volume:
6
Page:
753-753
Author(s):
Viral Vectors for Gene-Directed Enzyme Prodrug Therapy
Journal:
Current Gene Therapy
Volume:
6
Page:
647-670
Author(s):
Silke Schepelmann and Caroline J. Springer
The Redox Regulation of Thiol Dependent Signaling Pathways in Cancer
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
4427-4443
Author(s):
Gregory I. Giles
Nitric Oxide and the Regulation of Apoptosis in Tumour Cells
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
4445-4468
Author(s):
J. M. Tarr, P. Eggleton and P. G. Winyard
Targeting the EGFR Pathway for Cancer Therapy
Journal:
Current Medicinal Chemistry
Volume:
13
Page:
3483-3492
Author(s):
James B. Johnston, Sri Navaratnam, Marshall W. Pitz, Jerry M. Maniate, Emilia Wiechec, Heinrich Baust, Joel Gingerich, Georgios P. Skliris, Leigh C. Murphy and Marek Los
Nuclear Retinoic Acid Receptor Beta as a Tool in Chemoprevention Trials
Journal:
Current Medicinal Chemistry
Volume:
13
Page:
3553-3563
Author(s):
B. Pavan, C. Biondi and A. Dalpiaz
Ethnic Differences in Pharmacogenetically Relevant Genes
Journal:
Current Drug Targets
Volume:
7
Page:
1641-1648
Author(s):
R. M. Engen, S. Marsh, D. J. Van Booven and H. L. McLeod
Tumoricidal and Anti-Angiogenic Actions of Gamma-Linolenic Acid and Its Derivatives
Journal:
Current Pharmaceutical Biotechnology
Volume:
7
Page:
457-466
Author(s):
Undurti N. Das
Pharmacological Inhibitors of Fatty Acid Synthase (FASN)-Catalyzed Endogenous Fatty Acid Biogenesis: A New Family of Anti-Cancer Agents?
Journal:
Current Pharmaceutical Biotechnology
Volume:
7
Page:
483-494
Author(s):
Ruth Lupu and Javier A. Menendez